Stockreport

Orgenesis Completes Sale of Masthercell Subsidiary; Receives Approximately $127 Million in Net Proceeds

Orgenesis Inc.  (ORGS) 
NASDAQ:AMEX Investor Relations: orgenesis.com
PDF Sale reflects culmination of successful CDMO strategy initiated in 2015 and 59% 5-year CAGR of Masthercell under Orgenesis’ leadership Reports rapid progress in roll- [Read more]